SCHEMBL4182014

SCHEMBL4182014

CC(Oc1ccc(CN2C[C@@H](C)OC2=O)cn1)C1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852922 0.84 GRM2 (1.00) GRM2
SCHEMBL3855716 0.78 GRM2 (0.70) GRM2
SCHEMBL4179857 0.74 GRM2 (0.59) GRM2
SCHEMBL3856180 0.74 GRM2 (0.65) GRM2
SCHEMBL3868899 0.72 GRM2 (0.58) GRM2
SCHEMBL3852502 0.71 GRM2 (1.00) GRM2
SCHEMBL3871960 0.71 GRM2 (0.75) GRM2
SCHEMBL4182088 0.67 GRM2 (0.71) GRM2
SCHEMBL3860396 0.67 GRM2 (0.71) GRM2
SCHEMBL3850409 0.67 GRM2 (0.74) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137577-A1 HETEROCYCLIC COMPOUNDS PFIZER INC. 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137577-A1 HETEROCYCLIC COMPOUNDS CYP2D6, ABCG2, CYP2B6 GRM2 4432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.